Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

MR Solutions accelerates sales of its preclinical multi-modality, high field, cryogen free scanners

MR Solutions
Posted on: 06 Sep 16
MR Solutions accelerates sales of its preclinical multi-modality, high field, cryogen free scanners

 

·        Simultaneous and sequential PET-MR imaging systems with proven reference sites on show at 2016 WMIC in New York

 

MR Solutions continues to grow sales of its cryogen free, pre-clinical range of scanners including its PET-MR and high field MR systems. These include sales of its large bore cryogen free 7T MR systems to the University of Sydney, the Academic Medical Centre (AMC) in Amsterdam, and the USC-Zilkha Neurogenetic Institute in California which incorporate the MR Solutions PET insert for simultaneous imaging. As well as these multi- modality systems MR has recently delivered regular bore 7T MRI systems to research centres in Russia and China.

 

A 4.7T system was recently acquired by USC, San Diego with the IBS Centre for Nanomedicine in Korea acquiring the newest 3T cryogen free MR.

 

Since its first installation in 2012, MR Solutions has rapidly become the world leader and reference for cryogen free high field superconducting MR.

 

MR Solutions will be displaying their latest combined PET-MRI multi-modality imaging systems for preclinical research at the ninth annual 2016 World Molecular Imaging Congress (WMIC) in New York, from 7 to 10 September, 2016.

 

MR Solutions is the only manufacturer to offer both a complete range of cryogen free MRI systems (3T, 4.7T, 7T and 9.4T) and offer simultaneous or sequential PET and SPECT in combination with these scanners.

 

Dr David Taylor, physicist and CEO of MR Solutions said, “We believe that our cryogen free and multi-modality developments have completely disrupted the high field preclinical market place. We have spent millions of dollars in developing these technologies which we believe has opened up a large capability gap, between ourselves and our competitors.”

 

For simultaneous PET and MRI imaging, MR Solutions’ PET module is inserted within the bore of the MRI system. The multi-modality imaging scanner combines MRI for the exquisite structural and functional characterisation of tissue with the extreme sensitivity of PET imaging for metabolism and tracking of uniquely labelled cell types or cell receptors. This is particularly useful in oncology, cardiology, and neurology research. Superior imaging resolution results may be the best on the market at <0.7mm. 

 

MR Solutions also offers a sequential PET-MR imaging system by clipping on a PET module to the front of the MRI system. The imaging can then be carried out automatically from one modality to another on the same axis. The clip-on option allows independent use of MRI or PET imaging without the need to move subjects to different machines which may be located in different parts of a laboratory or research centre.

 

In a further development, MR Solutions can now provide SPECT imaging, based on multi-pinhole technology, for use with high field MRI systems or CT systems to provide PET/SPECT/CT multi-modality imaging. SPECT-MR is available for either sequential or simultaneous imaging.

 

MR Solutions has over 30 years’ experience and in excess of 1000 installations, including spectrometer sales, across the world. Its scanners are renowned for their excellence in terms of superior soft tissue contrast and molecular imaging ability.

 

MR Solutions has its global headquarters at Ashbourne House, The Guildway, Old Portsmouth Road, Guildford, Surrey GU3 1LR; tel: + 44 1483 532146; information@mrsolutions.com; www.mrsolutions.com.

For more information:
www.mrsolutions.com

Editor's Details

Leonie Onslow
Vane Percy & Roberts
01737821890
leonie@vanepercy.com

Last updated on: 06/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.